Tiansheng Pharmaceutical Group Co Ltd Market Cap ($269.89 Million)
Market Cap & Net Worth: Tiansheng Pharmaceutical Group Co Ltd (002872)
Tiansheng Pharmaceutical Group Co Ltd market cap. Tiansheng Pharmaceutical Group Co Ltd (SHE:002872) has a market capitalization of $269.89 Million (CN¥1.84 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #15044 globally and #4417 in its home market, demonstrating a 2.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tiansheng Pharmaceutical Group Co Ltd's stock price CN¥5.80 by its total outstanding shares 318000000 (318.00 Million). Also see Tiansheng Pharmaceutical Group Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Tiansheng Pharmaceutical Group Co Ltd Market Cap History (2017–2026)
Tiansheng Pharmaceutical Group Co Ltd market cap history from 2017 to 2026. Data shows change from $934.55 Million to $269.89 Million (-12.79% CAGR). Check latest Tiansheng Pharmaceutical Group Co Ltd stock price today for real-time trading data and today's change.
Tiansheng Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tiansheng Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Tiansheng Pharmaceutical Group Co Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.37x
Tiansheng Pharmaceutical Group Co Ltd's market cap is 0.37 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $934.55 Million | $2.26 Billion | $248.58 Million | 0.41x | 3.76x |
| 2018 | $398.33 Million | $2.17 Billion | $15.62 Million | 0.18x | 25.50x |
| 2019 | $249.88 Million | $1.68 Billion | -$218.94 Million | 0.15x | N/A |
| 2020 | $220.57 Million | $1.20 Billion | -$493.59 Million | 0.18x | N/A |
| 2021 | $242.90 Million | $736.69 Million | -$72.34 Million | 0.33x | N/A |
| 2022 | $245.70 Million | $606.99 Million | -$91.55 Million | 0.40x | N/A |
| 2023 | $238.72 Million | $579.33 Million | -$93.07 Million | 0.41x | N/A |
| 2024 | $211.26 Million | $569.71 Million | -$87.40 Million | 0.37x | N/A |
Competitor Companies of 002872 by Market Capitalization
Companies near Tiansheng Pharmaceutical Group Co Ltd in the global market cap rankings as of November 4, 2026. Also see 002872 total asset value for a full breakdown of the balance sheet.
Key companies related to Tiansheng Pharmaceutical Group Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Tiansheng Pharmaceutical Group Co Ltd (2017–2026)
Market capitalization of Tiansheng Pharmaceutical Group Co Ltd from 2017 to today. Between 2017 and today, Tiansheng Pharmaceutical Group Co Ltd's market cap moved from $934.55 Million to $ 269.89 Million, with a yearly change of -12.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥269.89 Million | +19.34% |
| 2025 | CN¥226.15 Million | +7.05% |
| 2024 | CN¥211.26 Million | -11.50% |
| 2023 | CN¥238.72 Million | -2.84% |
| 2022 | CN¥245.70 Million | +1.15% |
| 2021 | CN¥242.90 Million | +10.13% |
| 2020 | CN¥220.57 Million | -11.73% |
| 2019 | CN¥249.88 Million | -37.27% |
| 2018 | CN¥398.33 Million | -57.38% |
| 2017 | CN¥934.55 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Tiansheng Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $269.89 Million USD |
| MoneyControl | $269.89 Million USD |
| MarketWatch | $269.89 Million USD |
| marketcap.company | $269.89 Million USD |
| Reuters | $269.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more